You are here

  • Home
  • Archive
  • Volume 18, Issue 5
  • Topical NSAIDS provide effective pain relief for patients with hand or knee osteoarthritis with similar efficacy, and fewer side effects, than oral NSAIDS

Article Text

Article menu
Download PDFPDF
Therapeutics
Systematic review with meta-analysis
Topical NSAIDS provide effective pain relief for patients with hand or knee osteoarthritis with similar efficacy, and fewer side effects, than oral NSAIDS
  1. Andrew Östör,
  2. Pippa A Watson
  1. Department of Rheumatology, Addenbrooke's Hospital, Cambridge, UK
  1. Correspondence to : Andrew J K Östör
    Department of Rheumatology, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK; andrew.ostor{at}addenbrookes.nhs.uk

https://doi.org/10.1136/eb-2012-101083

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Derry S, Moore RA, Rabbie R. Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev 2012;9:CD007400.

    Context

    Topical non-steroidal anti-inflammatory drugs (NSAIDS) are readily available from chemists and supermarkets worldwide and are commonly used in the treatment of a number of painful conditions. Their overall efficacy in the long term, particularly in relation to chronic painful conditions such as osteoarthritis, has not been fully established.

    Methods

    Derry and colleagues have conducted a thorough and comprehensive review of the area including data from The Cochrane Library, MEDLINE, EMBASE and www.clinicaltrials.gov, as well as their in-house clinical trials registers from 2004 to June 2012. The selection criteria were clearly defined and the methodological quality of each study was appropriately assessed using the Oxford Quality Scale. The studies consisted of randomised double blind studies lasting ≥2 weeks …

    View Full Text

    Footnotes

    • Funding None.

    • Competing interests None.